Literature DB >> 26830892

P2X7R large pore is partially blocked by pore forming proteins antagonists in astrocytes.

Robson X Faria1, Ricardo A M Reis2, Leonardo G B Ferreira3, Paula F T Cezar-de-Mello4, Milton O Moraes4.   

Abstract

The ATP-gated P2X7R (P2X7R) is a channel, which is involved in events, such as inflammation, cell death, and pain. The most intriguing event concerning P2X7R functions is the phenomenon of pore dilation. Once P2X7R is activated, the permeability of the plasma membrane becomes higher, leading to the permeation of 1000 Da-weight solutes. The mechanisms involved in this process remain unclear. Nevertheless, this event is not exclusively through P2X7R, as other proteins may form large pores in the plasma membrane. Recent evidence concerning pore formation reveals putative P2X7R and other pores-associated protein complexes, revealing cross-interactive pharmacological and biophysical issues. In this work, we showed results that corroborated with cross-interactive aspects with P2X7R and pores in astrocytes. These cells expressed most of the pores, including P2X7R. We discovered that different pore types open with peculiar characteristics, as both anionic and cationic charged solutes permeate the plasma membrane, following P2X7R activation. Moreover, we showed that both synergic and additive relationships are found within P2X7, cationic, and anionic large pores. Therefore, our data suggest that other protein-related pores are assembled following the formation of P2X7R pore.

Entities:  

Keywords:  Electrophysiology; Hemichannel antagonists; Hemichannels; P2X7R; Pore formation

Mesh:

Substances:

Year:  2016        PMID: 26830892     DOI: 10.1007/s10863-016-9649-9

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  72 in total

1.  TRPA1 channels are regulators of astrocyte basal calcium levels and long-term potentiation via constitutive D-serine release.

Authors:  Eiji Shigetomi; Olan Jackson-Weaver; Robert T Huckstepp; Thomas J O'Dell; Baljit S Khakh
Journal:  J Neurosci       Date:  2013-06-12       Impact factor: 6.167

2.  Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions.

Authors:  Nicol Kruska; Peter Schönfeld; Aurora Pujol; Georg Reiser
Journal:  Biochim Biophys Acta       Date:  2015-01-10

3.  Functional recovery from desensitization of vanilloid receptor TRPV1 requires resynthesis of phosphatidylinositol 4,5-bisphosphate.

Authors:  Beiying Liu; Chunguang Zhang; Feng Qin
Journal:  J Neurosci       Date:  2005-05-11       Impact factor: 6.167

4.  Expression of P2X7 receptor increases in vivo tumor growth.

Authors:  Elena Adinolfi; Lizzia Raffaghello; Anna Lisa Giuliani; Luigi Cavazzini; Marina Capece; Paola Chiozzi; Giovanna Bianchi; Guido Kroemer; Vito Pistoia; Francesco Di Virgilio
Journal:  Cancer Res       Date:  2012-04-13       Impact factor: 12.701

5.  FGF-1 induces ATP release from spinal astrocytes in culture and opens pannexin and connexin hemichannels.

Authors:  Juan M Garré; Mauricio A Retamal; Patricia Cassina; Luis Barbeito; Feliksas F Bukauskas; Juan C Sáez; Michael V L Bennett; Verónica Abudara
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-10       Impact factor: 11.205

6.  Regulation of P2X7-induced pore formation and cell death in pericyte-containing retinal microvessels.

Authors:  Tetsuya Sugiyama; Hajime Kawamura; Shigeki Yamanishi; Masato Kobayashi; Kozo Katsumura; Donald G Puro
Journal:  Am J Physiol Cell Physiol       Date:  2004-10-20       Impact factor: 4.249

7.  Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action.

Authors:  C Marques-da-Silva; M M Chaves; N G Castro; R Coutinho-Silva; M Z P Guimaraes
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

8.  P2X7 receptor activation regulates microglial cell death during oxygen-glucose deprivation.

Authors:  Ukpong B Eyo; Sam A Miner; Katelin E Ahlers; Long-Jun Wu; Michael E Dailey
Journal:  Neuropharmacology       Date:  2013-06-12       Impact factor: 5.250

9.  Pharmacological properties of a pore induced by raising intracellular Ca2+.

Authors:  R X Faria; R A M Reis; C M Casabulho; A V P Alberto; F P de Farias; A Henriques-Pons; L A Alves
Journal:  Am J Physiol Cell Physiol       Date:  2009-03-25       Impact factor: 4.249

10.  Astrocytic TRPV1 ion channels detect blood-borne signals in the sensory circumventricular organs of adult mouse brains.

Authors:  Tetsuya Mannari; Shoko Morita; Eriko Furube; Makoto Tominaga; Seiji Miyata
Journal:  Glia       Date:  2013-03-07       Impact factor: 7.452

View more
  9 in total

1.  P2X7 receptor-targeted regulation by tetrahydroxystilbene glucoside in alcoholic hepatosteatosis: A new strategy towards macrophage-hepatocyte crosstalk.

Authors:  Yu Zhang; Min Jiang; Ben-Wen Cui; Cheng Hua Jin; Yan-Ling Wu; Yue Shang; Hong-Xu Yang; Mei Wu; Jian Liu; Chun-Ying Qiao; Zi-Ying Zhan; Huan Ye; Guang-Hao Zheng; Quan Jin; Li-Hua Lian; Ji-Xing Nan
Journal:  Br J Pharmacol       Date:  2020-02-23       Impact factor: 8.739

2.  Cannabinoids Induce Cell Death and Promote P2X7 Receptor Signaling in Retinal Glial Progenitors in Culture.

Authors:  Hércules Rezende Freitas; Alinny Rosendo Isaac; Thayane Martins Silva; Geyzzara Oliveira Ferreira Diniz; Yara Dos Santos Dabdab; Eduardo Cosendey Bockmann; Marília Zaluar Passos Guimarães; Karin da Costa Calaza; Fernando Garcia de Mello; Ana Lucia Marques Ventura; Ricardo Augusto de Melo Reis; Guilherme Rapozeiro França
Journal:  Mol Neurobiol       Date:  2019-03-05       Impact factor: 5.590

3.  P2X7 receptor large pore signaling in avian Müller glial cells.

Authors:  Robson X Faria; Hercules R Freitas; Ricardo A M Reis
Journal:  J Bioenerg Biomembr       Date:  2017-06-01       Impact factor: 2.945

4.  The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 in Pancreatic Cancer Cells.

Authors:  Lara Magni; Rayhana Bouazzi; Hugo Heredero Olmedilla; Patricia S S Petersen; Marco Tozzi; Ivana Novak
Journal:  Cells       Date:  2021-07-29       Impact factor: 6.600

Review 5.  Contribution of Müller Cells in the Diabetic Retinopathy Development: Focus on Oxidative Stress and Inflammation.

Authors:  Raul Carpi-Santos; Ricardo A de Melo Reis; Flávia Carvalho Alcantara Gomes; Karin C Calaza
Journal:  Antioxidants (Basel)       Date:  2022-03-23

6.  Human Cerebral Organoids and Fetal Brain Tissue Share Proteomic Similarities.

Authors:  Juliana Minardi Nascimento; Verônica M Saia-Cereda; Rafaela C Sartore; Rodrigo Madeiro da Costa; Clarissa S Schitine; Hercules Rezende Freitas; Michael Murgu; Ricardo A de Melo Reis; Stevens K Rehen; Daniel Martins-de-Souza
Journal:  Front Cell Dev Biol       Date:  2019-11-28

7.  P2X7R-NEK7-NLRP3 Inflammasome Activation: A Novel Therapeutic Pathway of Qishen Granule in the Treatment of Acute Myocardial Ischemia.

Authors:  Yanqin Li; Xiaoqian Sun; Xiangning Liu; Junjun Li; Xuan Li; Gang Wang; Yizhou Liu; Xiangyu Lu; Lingwen Cui; Mingyan Shao; Yong Wang; Wei Wang; Chun Li
Journal:  J Inflamm Res       Date:  2022-09-13

8.  Glutathione-Induced Calcium Shifts in Chick Retinal Glial Cells.

Authors:  Hercules R Freitas; Gabriel Ferraz; Gustavo C Ferreira; Victor T Ribeiro-Resende; Luciana B Chiarini; José Luiz M do Nascimento; Karen Renata H Matos Oliveira; Tiago de Lima Pereira; Leonardo G B Ferreira; Regina C Kubrusly; Robson X Faria; Anderson Manoel Herculano; Ricardo A de Melo Reis
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

Review 9.  Pore forming channels as a drug delivery system for photodynamic therapy in cancer associated with nanoscintillators.

Authors:  Luiz Anastacio Alves; Leonardo Braga Ferreira; Paulo Furtado Pacheco; Edith Alejandra Carreño Mendivelso; Pedro Celso Nogueira Teixeira; Robson Xavier Faria
Journal:  Oncotarget       Date:  2018-05-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.